Abiopharma

📋 Frank McCormick (Director) plans to sell 198K shares of BridgeBio Pharma (at $66.58 each, total $13.2M) Filed: Oct 29, 2025 | ID: 047224

Hill Stephen J. 🟢 acquired 75.0K shares (1 derivative) of Lyell Immunopharma, Inc. (LYEL) at $17.23 ($1.3M) Transaction Date: Oct 27, 2025 | Filing ID: 000005

Lee Gary K. 🟢 acquired 68.0K shares (1 derivative) of Lyell Immunopharma, Inc. (LYEL) at $17.23 ($1.2M) Transaction Date: Oct 27, 2025 | Filing ID: 000005

Seely Lynn 🟢 acquired 175.0K shares (1 derivative) of Lyell Immunopharma, Inc. (LYEL) at $17.23 ($3.0M) Transaction Date: Oct 27, 2025 | Filing ID: 000006

(99% Neutral) Predictive Oncology Inc. (POAI) Announces Business Combination

New Form 424B5 - Predictive Oncology Inc. Filed: 2025-10-29 AccNo: 0001171843-25-006771 Size: 24 KB

New Form SCHEDULE 13G - TENAX THERAPEUTICS, INC. Filed: 2025-10-29 AccNo: 0000902664-25-004624 Size: 16 KB

New Form SCHEDULE 13G - Compass Therapeutics, Inc. Filed: 2025-10-29 AccNo: 0000921895-25-002825 Size: 38 KB

New Form SCHEDULE 13D/A - Evotec SE Filed: 2025-10-29 AccNo: 0001193125-25-256684 Size: 13 KB

(75% Positive) Vistagen Therapeutics, Inc. (VTGN) Provides Update on leadership for Vistagen